---
title: "UBS Keeps Their Hold Rating on Cochlear  (CHEOF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302231742.md"
description: "In a report released today, David Low from UBS maintained a Hold rating on Cochlear , with a price target of A$135.00. Low covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Cochlear . According to TipRanks, Low has an average return of 5.3% and a 51.45% success rate on recommended stocks. Cochlear has an analyst consensus of Hold, with a price target consensus of A$138.35."
datetime: "2026-10-19T02:35:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302231742.md)
  - [en](https://longbridge.com/en/news/302231742.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302231742.md)
generator: "portal-rs"
---

# UBS Keeps Their Hold Rating on Cochlear  (CHEOF)

In a report released today, David Low from UBS maintained a Hold rating on Cochlear , with a price target of A$135.00.

Low covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Cochlear . According to TipRanks, Low has an average return of 5.3% and a 51.45% success rate on recommended stocks. 

Cochlear has an analyst consensus of Hold, with a price target consensus of A$138.35.

### Related Stocks

- [CHEOY.US](https://longbridge.com/en/quote/CHEOY.US.md)
- [COH.AU](https://longbridge.com/en/quote/COH.AU.md)
- [CSL.AU](https://longbridge.com/en/quote/CSL.AU.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)

## Related News & Research

- [Cochlear® Nucleus® Nexa® System Named One of TIME's Best Inventions of 2026](https://longbridge.com/en/news/302415256.md)
- [Citi Keeps Their Hold Rating on Cochlear  (CHEOF)](https://longbridge.com/en/news/298516761.md)
- [UBS Keeps Their Hold Rating on Cochlear  (CHEOF)](https://longbridge.com/en/news/291346274.md)
- [Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026](https://longbridge.com/en/news/301862137.md)
- [Macquarie Sticks to Its Hold Rating for Cochlear  (CHEOF)](https://longbridge.com/en/news/300498716.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**